United States· US:58160-976_db17d990-e6e2-450c-b9ed-923ec92df84d
Bexsero
A medicinal product containing neisseria meningitidis group b nhba fusion protein antigen; neisseria meningitidis group b fhbp fusion protein antigen; neisseria meningitidis group b nada protein antigen; neisseria meningitidis group b strain nz98/254 outer membrane vesicle antigen, registered in United States by GlaxoSmithKline Biologicals SA.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11581609762010 SYRINGE in 1 CARTON (58160-976-20) / .5 mL in 1 SYRINGE (58160-976-02)
- ndc1158160-976-20
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf3b12df-c50a-4587-985c-f872c5173cf7 GET /v1/drugs/bf3b12df-c50a-4587-985c-f872c5173cf7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR",
"source": "ndc",
"strength": "50; 50; 50; 25",
"substance": "NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN",
"productndc": "58160-976",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL",
"application_number": "BLA125546",
"marketing_category": "BLA"
}See everything about neisseria meningitidis group b nhba fusion protein antigen; neisseria meningitidis group b fhbp fusion protein antigen; neisseria meningitidis group b nada protein antigen; neisseria meningitidis group b strain nz98/254 outer membrane vesicle antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.